Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16186518 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis
Conditions: Multiple Sclerosis;   Neuropathic Pain
Interventions: Drug: Placebo;   Drug: Sativex

Indicates status has not been verified in more than two years